Vale Indonesia Tbk (INCO IJ) Missed Arrow
Bottom Line: Higher than Consensus but Lower than Our Estimate In 3Q18, INCO posted the net profit of USD25.8 million
Kalbe Farma Tbk (KLBF) Stable Growth
Single-Digit Growth in Sales KLBF is projected to post the growth of 3.4% in 2018’s sales. The growth is a lot lower
Jasa Armada Indonesia Tbk (IPCM) Is Akin to Marathon Runner
Is 2018’s Revenue Target Accomplished? We conduct a site visit to IPCM a few weeks ago. In the early of 2018, IPCM
Kimia Farma Tbk (KAEF) Aggressive Expansions
Increment of 20.2% in Sales KAEF’s sales are projected to surge by 20.2% from IDR6.12 trillion in 2017 to IDR7.36
XL Axiata Tbk (EXCL) Focus on Development of Data Segment
Partnership and Marketing: Fruitful Strategies In 2Q18, EXCL’s performance nudged up by 1% q-q and in 1H18 it also
Medco Energi Internasional Tbk (MEDC) 3Q18’s Preview of Shirking Debt Portion
3Q18 Projection of Upbeat ASP Bolstering Revenue Overseeing that global oil and gas prices are on rise, we project
Telekomunikasi Indonesia Tbk (TLKM) Endeavors to Stabilize Performance
Facing Transitional Periods TLKM’s endeavors to stabilize its revenues after sluggish performance were quite
PP London Sumatra Indonesia Tbk (LSIP) Awaits for Hike in CPO Prices
Suppressed CPO Selling Prices LSIP posted the decrease of 10.8% in sales from IDR1.0 trillion in 2Q17 to IDR894.9
AKR Corporindo Tbk (AKRA) 3Q18’s Expectancy of Solid Core Business Performance
Asset Divestment, Strengthening Bottom Line We estimate AKRA to post the net profit of IDR905 billion (+446% q-q) and
